Key Quantitative Figures

  • Open Offer Size: 794,170 equity shares (26.00% of voting share capital)
  • Offer Price: ₹30 per fully paid-up equity share
  • Total Offer Consideration: ₹2,38,25,100 (if fully subscribed)
  • Underlying Transaction Shares: 1,407,000 equity shares (46.06% of voting capital)
  • Underlying Transaction Value: ₹4,22,10,000
  • Face Value per Share: ₹10
  • Target Company Total Shares: 3,054,500 (implied from 46.06% = 1,407,000 shares)

Parties Involved

Acquirers:

  • Mr. Pankaj Grover (Acquirer 1) - PAN: AHIPG0883G, Address: 207-B, 2nd Floor, I-Block, Near Water Tank, South City-II, Gurgaon, Haryana-122018
  • Mr. Abhisek Gupta (Acquirer 2) - PAN: BGXPG3508B, Address: Flat No.-11164, Ats Advantage, Ahinsa Khand -1, Indirapuram, Sahibabad, Ghaziabad, Uttar Pradesh-201010

Selling Shareholder:

  • Mr. Yogesh Agrawal (Promoter Seller) - sold 1,407,000 shares (46.06% holding)

Target Company:

  • Genomic Valley Biotech Limited (CIN: L01122HR1994PLC033029)
  • Corporate Office: G-74, Pushkar Enclave, Paschim Vihar, Delhi-110063
  • BSE Scrip Code: 539206, ISIN: INE574D01010

Manager to the Offer:

  • Fintellectual Corporate Advisors Private Limited (SEBI Registration: INM000012944)
  • Address: B-20, Second Floor, Sector-1, Noida, Uttar Pradesh-201301
  • Contact: Mr. Amit Puri, Director (DIN: 09081387)

Transaction Details

Underlying Transaction:

  • Direct acquisition via Share Purchase Agreement
  • Mode: Cash payment
  • Acquisition of 1,407,000 shares (46.06% voting capital) from promoter Yogesh Agrawal
  • Price: ₹30 per share, totaling ₹4,22,10,000
  • Triggered under Regulations 3(1) and 4 of SEBI (SAST) Regulations

Post-Transaction Shareholding:

  • Pankaj Grover: 907,000 shares (29.69%)
  • Abhisek Gupta: 500,000 shares (16.37%)
  • Combined: 1,407,000 shares (46.06%)

Conditions and Provisions

  • Offer is not conditional upon minimum acceptance (Regulation 19(1))
  • Not a competing offer (Regulation 20)
  • Completion subject to conditions precedent in Share Purchase Agreement
  • Underlying transaction may complete prior to open offer completion
  • Acquirers have provided undertaking of adequate financial resources

Mode of Payment

  • Offer price will be paid in cash as per Regulation 9(1)(a) of SEBI (SAST) Regulations

Additional Information

  • Equity shares are frequently traded as per Regulation 2(1)(j) of SEBI (SAST) Regulations
  • Offer price determined in accordance with Regulations 8(1) and 8(2)
  • Public Shareholders exclude promoters, acquirers, persons acting in concert, and parties to SPA